Natural EVs in cancer therapy. a) TEX stimulate immune activation by

Download scientific diagram | Natural EVs in cancer therapy. a) TEX stimulate immune activation by boosting T‐cell expansion and function via APCs especially DC cells. DEX activate T cells by mimicking the role of APCs. b) NK‐cell‐derived EVs induce tumor cell death through FasL, perforin, and TNF‐α. c) EVs from M1 macrophages can re‐educate tumor associated macrophages from M2 to M1 phenotype, which further activates anti‐tumor immunity. d) Stem‐cell‐derived EVs inhibit the growth of tumor cells through miRNA‐mediated mechanisms. Abbreviations: DC cell, dendritic cell; DEX, dendritic cell‐derived EVs; FasL, Fas ligand; M1 EVs, M1 macrophage‐derived EVs; MHC, major histocompatibility complex; MSCs, mesenchymal stem cells; NK EVs, NK cell‐derived EVs; TCR, T cell receptor; TEX, tumor cell‐derived EVs; TNF‐α, tumor necrosis factor‐α; TNFR, tumor necrosis factor receptor. from publication: Engineered Extracellular Vesicles for Cancer Therapy | Extracellular vesicles (EVs) have emerged as a novel cell-free strategy for the treatment of many diseases including cancer. As a result of their natural properties to mediate cell-to-cell communication and their high physiochemical stability and biocompatibility, EVs are | Extracellular Vesicles, Cancer Therapy and Bioinspired | ResearchGate, the professional network for scientists.

Bacterial extracellular vesicle applications in cancer immunotherapy - ScienceDirect

Engineered extracellular vesicles and their mimetics for cancer immunotherapy - ScienceDirect

Potential roles of extracellular vesicles in the pathophysiology, diagnosis, and treatment of autoimmune diseases

Frontiers Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma

Antiviral CD8+ T-cell immune responses are impaired by cigarette smoke and in COPD

Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses

Natural EVs in cancer therapy. a) TEX stimulate immune activation by

Cancers, Free Full-Text

Senescent T cells: a potential biomarker and target for cancer therapy - eBioMedicine

Frontiers Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy

Emerging applications of extracellular vesicles in tumor therapy, Cancer Nanotechnology